Oct 21, 2005 by Stephen D. SimpsonReady, Set, Grow, XeroxXerox is past the point of imminent collapse, but not yet a certain success.
Oct 21, 2005 by Stephen D. SimpsonIgnoble Treatment of NobleDespite a 15% drop over the past few weeks, the market for offshore drilling is good and getting better.
Oct 21, 2005 by Stephen D. SimpsonMaster of Its DominionOld Dominion continues to gain share and produce growth with an easily understandable business.
Oct 20, 2005 by Stephen D. SimpsonLilly Steady As She GoesIn-line performance is probably the best that investors could have hoped for this quarter.
Oct 20, 2005 by Stephen D. SimpsonDanaher Does It AllConglomerates don't often get their proper due. This one is worth a closer look.
Oct 20, 2005 by Stephen D. SimpsonWide Eyes at AlconExcellent margin performance fueled exceptional growth for this eye-care titan.
Oct 20, 2005 by Stephen D. SimpsonIndustrious Profits for Ingersoll-RandThis industrial conglomerate still looks attractively priced.
Oct 20, 2005 by Stephen D. SimpsonBaxter Needs Growth InfusionThis is a fine health-care company, but a sluggish top line suggests there are limits to how far it can go.
Oct 20, 2005 by Stephen D. SimpsonPfizer FizzlesDisappointing guidance could have this giant pharmaceutical company retesting its lows.
Oct 19, 2005 by Stephen D. SimpsonAbbott Still a Little PalePerhaps drug and device pipelines, plus margin improvements, can put some color back into the stock.
Oct 19, 2005 by Stephen D. SimpsonCDW: Where's the Love?It's a proven grower in a growth industry -- but investors keep yawning.
Oct 19, 2005 by Stephen D. SimpsonICU, You Look HealthierAn incredible third quarter shows what operating leverage can do for this little medical technology company.
Oct 19, 2005 by Stephen D. SimpsonHoneywell May Be on AutopilotCan this huge conglomerate stay ahead of maturing markets?
Oct 19, 2005 by Stephen D. SimpsonCan JPMorgan Keep Growing?JPMorgan is a huge company, but that doesn't necessarily mean it can't get bigger.
Oct 19, 2005 by Stephen D. SimpsonStryker Still on TargetThe ever-present 20% growth target will get tougher to hit, but this is a quality medical company.
Oct 19, 2005 by Stephen D. SimpsonTCF Is on TrackAlthough the bank's expansion strategies pose risks, profitability is exceptional.
Oct 19, 2005 by Stephen D. SimpsonU.S. Bancorp: Cheap Can Be BeautifulIncredible cost consciousness means excellent returns and performance for this Midwestern bank.
Oct 19, 2005 by Stephen D. SimpsonTooling Around Illinois Tool WorksThe valuation outlook on this diversified manufacturing company is mixed.
Oct 19, 2005 by Stephen D. SimpsonA Solid Base for Bank of AmericaWhile trying to grow in seemingly every direction at once, it still has a good business.
Oct 18, 2005 by Stephen D. SimpsonMore Good News From NovartisThis Swiss drug giant continues to post steady growth.
